Form 4 for GTBP GT Biopharma, Inc.
Accepted 2022-02-14 00:00:00 ET · period of report 2021-02-16 · accession 0001654954-22-001643 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-14 | 2021-02-16 | GTBP | Berk Gregory | Dir | A - Grant | $0.00 | +278.1K | 278.1K | New | $0 |
| D | 2022-02-14 | 2021-02-16 | GTBP | Berk Gregory | Dir | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-02-16 | A | A | 278,058 | $0.00 | 278,058 | D | — | — | (F1) Represents a grant of shares of restricted stock ("RSAs") in connection with the reporting person's services as a director. 1/3rd of the RSAs vest on November 11, 2020, 2021 and 2022. The reporting person resigned as a director on April 23, 2021. |
| 2 | Derivative | Option to purchase Common Stock | 2021-02-16 | A | A | 50,000 | $0.00 | 50,000 | D | $6.33 · — to 2031-02-15 | 50,000 Common Stock | (F2) Represents a grant of options in connection with the reporting person's services as a director. 13rd of the shares underlying the options vest on February 16, 2021, 2022 and 2023. |